Cargando…
mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia
The interplay between bone and glucose metabolism has highlighted hyperglycemia as a potential risk factor for bone diseases. With the increasing prevalence of diabetes mellitus worldwide and its subsequent socioeconomic burden, there is a pressing need to develop a better understanding of the molec...
Autores principales: | Wang, Shuangcheng, Wang, Jiale, Wang, Shuangwen, Tao, Ran, Yi, Jianru, Chen, Miao, Zhao, Zhihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252649/ https://www.ncbi.nlm.nih.gov/pubmed/37298150 http://dx.doi.org/10.3390/ijms24119198 |
Ejemplares similares
-
PPARβ/δ accelerates bone regeneration in diabetic mellitus by enhancing AMPK/mTOR pathway-mediated autophagy
por: Chen, Miao, et al.
Publicado: (2021) -
Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia
por: Luo, Meng, et al.
Publicado: (2023) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Kaempferol promotes bone formation in part via the mTOR signaling pathway
por: Zhao, Jing, et al.
Publicado: (2019) -
Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway
por: Wu, Han, et al.
Publicado: (2021)